Skip to content

Glycemic Index and CVD: a Crossover Feeding Study

Glycemic Index, Obesity, Insulin Resistance and CVD Risk, Part 2

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00141076
Enrollment
24
Registered
2005-09-01
Start date
2003-10-31
Completion date
2006-07-31
Last updated
2010-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

obesity, glycemic index, insulin resistance, cardiovascular disease, diabetes

Brief summary

This study will compare the physiological effects of two isoenergetic, nutrient-controlled diets that differ in glycemic index. The diets will be studied in obese adults in a 10-day crossover feeding trial.

Detailed description

This study will compare the physiological effects of two isoenergetic, nutrient-controlled diets that differ in glycemic index. The diets will be studied in obese male adults in a 10-day crossover feeding trial. Hypothesis: Obese subjects will show improvements in clinical endpoints associated with risk for diabetes and cardiovascular disease (CVD) after consuming a controlled low (compared to high) glycemic index diet for 10 days. 1º endpoint: insulin sensitivity as measured by the modified Frequently Sampled Intravenous Glucose Tolerance Test (FSIVGTT). 2º endpoints: CVD risk factors; postprandial studies of oxidative stress; thermic effect of food.

Interventions

BEHAVIORALlow vs high glycemic index diet

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Charles H. Hood Foundation
CollaboratorOTHER
Boston Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* age 18 to 35 years * male * BMI ≥ 27 ≤45 kg/m2 * willingness to refrain from alcohol and caffeinated beverage consumption for duration of study

Exclusion criteria

* major medical illness * an abnormal screening laboratory test * taking any prescription medications that might affect body weight * current smoking (1 cigarette during any of the last 7 days) * consuming special diets

Design outcomes

Primary

MeasureTime frame
Insulin sensitivity as measured by FS-IVGTT

Secondary

MeasureTime frame
CVD risk factors
Postprandial studies of oxidative stress
Thermic effect of food

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026